(Q54353014)

28 May 2018

title

Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients. (English)

1 reference

28 May 2018

1 reference

1 reference

Feng Qiu

1

1 reference

28 May 2018

Xiao-Jing He

2

1 reference

28 May 2018

Ya-Xin Sun

3

1 reference

28 May 2018

Jesse Li-Ling

4

1 reference

28 May 2018

Li-Mei Zhao

5

1 reference

28 May 2018

publication date

1 May 2011

1 reference

28 May 2018

published in

Pharmacological Reports

1 reference

28 May 2018

volume

63

1 reference

28 May 2018

issue

3

1 reference

28 May 2018

page(s)

815-825

1 reference

28 May 2018

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Influence of CYP3A5 genetic polymorphism on cyclosporine A metabolism and elimination in Chinese renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

The influence of CYP3A gene polymorphisms on cyclosporine dose requirement in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Pharmacogenomics--drug disposition, drug targets, and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

The genetic determinants of the CYP3A5 polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Review: metabolism of immunosuppressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Identification of functionally variant MDR1 alleles among European Americans and African Americans

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2).

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Frequencies and roles of CYP3A5, CYP3A4 and ABCB1 single nucleotide polymorphisms in Italian teenagers after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Active secretion and enterocytic drug metabolism barriers to drug absorption

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

Effect of bifendate on the pharmacokinetics of cyclosporine in relation to the CYP3A4*18B genotype in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970594-1

7 January 2021

10.1016/S1734-1140(11)70594-1

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018